Skip to main content

Table 3 Laboratory results of the studied groups

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

  Cirrhosis group
N=50
HCC group
N=50
Test of significance
INR 1.49±0.37 1.29±0.34 t=2.68
p=0.009*
Albumin (g/dl) 3.12±0.49 2.83±0.77 t=2.29
p=0.024*
AST (IU/ml) 55.70±37.29 95.0±73.97 z=3.21
p=0.001*
ALT (IU/ml) 46.50±24.52 60.22±41.63 z=1.44
p=0.149
Platelet/cm (×  103) 106.22±42.06 88.02±39.54 z=2.23
p=0.001*
WBCs/cm 5.74±2.61 6.44±2.96 z=1.18
p=0.235
Hgb (g/dl) 9.11±0.97 9.71±1.73 t=2.12
p=0.036*
Creatinine (mg/dl) 1.11±0.37 1.18±0.49 t=0.851
p=0.397
Total bilirubin (mg/dl) 2.76±2.7 5.09±5.27 z=2.82
p=0.005*
Direct bilirubin (mg/dl) 1.67±2.06 3.15±3.6 z=2.19
p=0.028*
  1. *Statistically significant (if p< 0.05)